Drug Database
OX

Oxalyt-C

✓ Approved

Rottapharm Madaus · 小分子 · 小分子

什么是 Oxalyt-C?

Oxalyt-C 是一种小分子,由Rottapharm Madaus研发。该药已获批,用于治疗相关适应症。

药物档案

公司Rottapharm Madaus
药物类别小分子
状态Approved

治疗适应症

Oxalyt-C 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Renal and urinary disordersCalculus urinary✓ Approved

相关研究文献

PubMedBMC cardiovascular disorders2026-11-18

Association between LDL-C/HDL-C ratio and atrial fibrillation risk in chronic heart failure patients.

Yan Senbo S, Hong Xuhui X, Chen Lu L, Lin Xiaohong X

Lipid levels are negatively correlated with atrial fibrillation (AF) in the general population. We aimed to investigate the correlation between low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio and AF in chronic heart failure (CHF). We enrolled 1,294 consecutive CHF patients. The LDL-C/HDL-C ratio was categorized into quartiles: Q1 (< 1.80), Q2 (1.80-2.43), Q3 (2.44-3.29), and Q4 (> 3.29). The relationship between the LDL-C/HDL-C ratio and AF in patients with CHF was analyzed by univariate and multivariate analyses through binary logistic regression, and sensitivity and subgroup analyses were performed for the multivariate results to validate the robustness of the multivariate results and assess the influence of confounding variables. The LDL-C/HDL-C ratio was inversely associated with the prevalence of AF in patients with CHF. When modeled by quartiles as a categorical variable, the trend P-value remained consistent with the continuous analysis. Sensitivity analyses excluding patients with stroke, dilated cardiomyopathy, or atherosclerosis confirmed the association (full model P for trend < 0.05), indicating robust results. In subgroup analyses, the association was not significantly influenced by confounding variables (P for interaction > 0.05). The LDL-C/HDL-C ratio was independently and inversely associated with prevalent AF among patients with chronic heart failure. This readily available metric may help identify CHF patients who could benefit from enhanced AF screening.

PMID 43045966
阅读全文 →
PubMedJournal of oral and maxillofacial pathology : JOMFP2026-11-18

Role of c-Myc mediated p53 dependent pathway in the progression of oral potentially malignant disorders and oral squamous cell carcinoma.

Yadav Shefali S, Shetty Devi Charan DC, Gulati Nikita N, Juneja Saurabh S et al.

The concomitant presence of Cellular Myelocytomatosis Oncogene (c-Myc) and p53 in their altered states in various forms and numbers is not as straight forward in the causation of oral cancer and Oral Potentially Malignant Disorders (OPMDs). However, the relationship between c-Myc and p53 immunoexpression during oral carcinogenesis remains incompletely understood. To evaluate the immunohistochemical expression of c-Myc and p53 in OPMDs and Oral Squamous Cell Carcinoma (OSCC) and to assess their relationship with the proliferative and differentiated compartments and nuclear grading. A cross-sectional study was conducted using archival tissue specimens comprising histopathologically confirmed cases of OPMDs and OSCC. A total of 30 histolopathologically confirmed cases of each OSCC and OPMDs was considered as study sample. Immunohistochemistry was performed for c-Myc and p53 in samples fixed in 10% neutral buffered formalin. Categorical variables were compared using the Chi-square test. Differences in mean c-Myc/p53 expression ratios across nuclear grades were assessed using one-way analysis of variance (ANOVA). Association of c-Myc and p53 immunoexpression was evaluated using Pearson's correlation coefficient. A P value ≤ 0.05 was considered statistically significant. The results were variable with majority of them showing wide variation between c-Myc and p53 labelling index followed by minor variation in the labelling index of c-Myc and p53. Few of the cases also depicted negative correlation amongst c-Myc and p53 immunoexpression. Variation of c-Myc immunoexpression within samples reflects biological alteration of mutated cell. Additionally, overexpression of c-Myc synergizes with p53 in maintaining the proliferative potential of the cell.

PMID 43048156
阅读全文 →
PubMedChemical communications (Cambridge, England)2026-11-18

Iron-catalyzed room temperature olefin formation via C(sp3)-H/C(sp3)-H double cross-dehydrogenative coupling: synthesis of enaminodiones.

Pinto Viona V, Lewis Ruther T RT, Babu Beneesh P BP

Herein, we report an intermolecular olefination of C-H bonds at the expense of four C(sp3)-H bonds catalyzed by Fe(III) salt at room temperature. A carbon-carbon double bond was formed between N-methylanilines and cyclic 1,3-diones via cross-dehydrogenative coupling, affording enaminodiones. Furthermore, the enaminodiones were converted into indazole and benzoxazole derivatives.

PMID 43046884
阅读全文 →
PubMedBMC pregnancy and childbirth2026-11-18

Analysis of 58 cases of cervical pregnancy and literature review.

Li Zhuyin Z, Jia Ruolin R, Huang Jie J, Shen Qi Q et al.

This study aimed to investigate the efficacy and prognosis of different treatment modalities in patients with cervical pregnancy. Clinical data of 58 patients diagnosed with cervical pregnancy admitted to the Obstetrics and Gynecology ward of the Third Affiliated Hospital of Zhengzhou University during the period from September 2014 to September 2024 were retrospectively analyzed as the study subjects, and according to the different treatment modes of the patients, patients were categorized into Group A[n = 13, treated with methotrexate (MTX) + mifepristone drug therapy in addition to ultrasound-guided uterine curettage], Group B [n = 19, treated with UAE in addition to ultrasound-guided uterine curettage] and Group C [n = 26, treated with direct ultrasound-guided uterine curettage(D&C alone)]. The general clinical data and intraoperative and postoperative conditions of the patients in the three groups were collected by retrospective analysis and statistical analysis. A total of 58 patients with cervical pregnancy were included and divided into three groups: Group A (MTX + mifepristone + D&C, n = 13), Group B (UAE + D&C, n = 19), and Group C (D&C alone, n = 26). There were no significant differences among the three groups in baseline characteristics, including age, gestational age, mode of conception, gravidity, preoperative β-hCG levels, and gestational sac size(Width and Thickness) ( P > 0.05). No patient in any group required a hysterectomy. Intraoperative blood loss showed no significant difference among groups (P > 0.05), although severe bleeding (≥ 300 mL) occurred more frequently in Group C (n = 8) than in Group A (n = 2) and Group B (n = 3). Group A had significantly longer hospital stays compared with Group B and Group C (P < 0.05). Hospitalization costs were significantly lower in Group C than in Groups A and B (P < 0.05). There was no significant difference in postoperative day 3 β-hCG levels among the three groups (P > 0.05). However, the time to β-hCG normalization was significantly shorter in Groups A and B than in Group C (P < 0.05). In the case of cervical pregnancy, individualized and combined treatment regimens should be chosen according to the patient's condition to achieve optimal therapeutic outcomes.

PMID 43046155
阅读全文 →
PubMedBioelectricity2026-11-18

Membrane Potential Bistability in Human Breast Cancer MDA-MB-231 Cells: A "Hodgkin-Huxley Type" Model.

De Suvabrata S, Djamgoz Mustafa B A MBA

The plasma membrane voltage ( V m ) is well known to have significant involvement in a wide range of cellular functions including cancer progression. Voltage imaging revealed that V m of MDA-MB-231 breast cancer cells is "bistable" with hyperpolarizing voltage transients (HVTs). Here, we formulate a model of V m incorporating the ion channels N a v 1.5 , C a v 3.2 , and K Ca 1.1 . V m is governed by the Hodgkin-Huxley formalism coupled to intracellular C a 2 + dynamics, via C a 2 + influx through C a v 3.2 and C a 2 + -dependent efflux of K + through K Ca 1.1 . Stochastic fluctuations-arising from sparse ion channel expression and C a 2 + -induced C a 2 + release (CICR)-drive V m transitions between the otherwise stable depolarized and hyperpolarized states. The model qualitatively reproduces the key experimental observations of HVTs, and their suppression by specific inhibitors of N a v 1.5 or K Ca 1.1 . It is predicted that inhibition of CICR should also lead to suppression of HVTs. Our model promises to help the understanding of the dynamic electrical activity of the MDA-MB-231 cell model and its functional consequences, and may inspire future bioelectricity-based cancer diagnosis and therapy.

PMID 43047690
阅读全文 →
PubMedNature communications2026-11-18

Alkali hydrides catalyze hydrogenolysis of polystyrene to alkylbenzenes under mild conditions.

Li Zhao Z, Cai Yongli Y, Tan Khai C KC, Liu Bing B et al.

This study introduces a highly efficient, transition-metal-free method for upcycling polystyrene (PS) waste using alkali metal hydrides, specifically KH, as a catalyst. Operating under mild conditions (130 °C, 1 bar H₂, 3 hours), KH achieves an impressive 93.2% yield of gaseous products and alkylbenzenes, with 95.8% selectivity toward alkylbenzenes. The production rate of 313.3 mmolcarbon/gKH/h is approximately 2.6 times higher than noble-metal catalysts operating at much higher temperatures (280 °C). This versatile approach is effective on diverse real-life PS waste. Mechanistically, depolymerization is driven by a synergy between direct hydride-induced Hδ+(C) abstraction and K+···π interactions with adjacent phenyl rings. This interaction elongates the C(sp³)-C(sp³) bonds, facilitating targeted cleavage into alkylbenzenes. Ultimately, this work establishes hydride catalysis as an energy-efficient platform for plastic depolymerization, providing crucial insights for designing mild-condition catalysts to address the global plastic waste crisis.

PMID 43045705
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多Oxalyt-C